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Abstract 
Barrier to autointegration factor (BAF) is a DNA-binding protein found in the nucleus and 
cytoplasm of eukaryotic cells that functions to establish nuclear architecture during mito-
sis. Herein, we demonstrate a cytoplasmic role for BAF in host defense during poxviral 
infections. Vaccinia is the prototypic poxvirus, a family of DNA viruses that replicate ex-
clusively in the cytoplasm of infected cells. Mutations in the vaccinia B1 kinase (B1) com-
promise viral DNA replication, but the mechanism by which B1 achieves this has remained 
elusive. We now show that BAF acts as a potent inhibitor of poxvirus replication unless its 
DNA-binding activity is blocked by B1-mediated phosphorylation. These data position 
BAF as the effector of an innate immune response that prevents replication of exogenous 
viral DNA in the cytoplasm. To enable the virus to evade this defense, the poxviral B1 has 
evolved to usurp a signaling pathway employed by the host cell. 
  
W I E B E  A N D  T R A K T M A N ,  C E L L  H O S T  &  M I C R O B E  1  (2 0 0 7 )  
2 
Introduction 
 
The barrier to autointegration factor (BAF) is an 89 amino acid dimeric DNA-binding pro-
tein found in both the nucleus and cytoplasm of many cell types. BAF has been shown to 
participate in nuclear reorganization during mitosis and is thought to facilitate nuclear re-
assembly by interacting with both DNA and inner nuclear membrane proteins, thus acting 
as a bridge to recruit chromatin to the nuclear periphery (Furukawa et al., 2003; Haraguchi 
et al., 2001; Margalit et al., 2005; Segura-Totten et al., 2002; Segura- Totten and Wilson, 2004; 
Shumaker et al., 2001). The contribution of cytoplasmic BAF to cell function has remained 
obscure, although it has been found to act as a retroviral cofactor. Specifically, cytoplasmic 
BAF has been found within retroviral preintegration complexes (PICs), where it prevents 
autointegration of proviral DNA in vitro; a role for BAF during the integration of the HIV 
and MLV proviral DNA into the cellular genome may also occur but is currently somewhat 
controversial (Chen and Engelman, 1998; Harris and Engelman, 2000; Jacque and Steven-
son, 2006; Lee and Craigie, 1998; Lin and Engelman, 2003; Shun et al., 2007). The roles of 
BAF both during normal cell division and retroviral infection rely heavily on its ability to 
bind double-stranded DNA in a sequence-independent manner. This binding involves au-
tonomous domains on each BAF monomer (Bradley et al., 2005; Harris and Engelman, 
2000; Segura-Totten et al., 2002; Zheng et al., 2000). 
Given the fact that BAF participates in the process of nuclear envelope assembly/disas-
sembly during mitosis, its temporal and/or spatial regulation by posttranslational modifi-
cations has seemed likely. Indeed, we have recently reported that the binding of BAF to 
DNA in vitro is strongly inhibited upon the phosphorylation of its N terminus by the cel-
lular vaccinia-related kinases VRK-1 and VRK-2 (Nichols et al., 2006). The sites on which 
BAF is phosphorylated by VRKs are highly conserved in diverse eukaryotes and can be 
similarly phosphorylated in vitro by the closely related B1 protein kinase encoded by vac-
cinia virus (Nichols et al., 2006). (The nomenclature B1, which has been used in the litera-
ture, refers to the fact that this viral protein is encoded by the first ORF in the HindIII B 
fragment of the viral genome; since the complete sequence of the WR strain has been com-
pleted, the nomenclature WR183 has also been introduced for this gene.) However, a role 
for BAF phosphorylation during poxviral infection has not been elucidated. 
Vaccinia is the prototypic member of the poxvirus family, which comprises complex 
DNA viruses whose more notorious members include the etiological agents of smallpox 
and monkeypox. These DNA viruses are unique in that they replicate exclusively in the 
cytoplasm of infected cells. The vaccinia B1 kinase is an essential protein that is expressed 
at early times after infection and encapsidated at low levels in nascent virions (Banham 
and Smith, 1992; Lin et al., 1992; Rempel and Traktman, 1992). Importantly, mutations 
which disrupt B1 compromise viral DNA replication and therefore the production of in-
fectious virus (Boyle and Traktman, 2004; Rempel et al., 1990; Rempel and Traktman, 1992). 
The mechanism through which B1 contributes to DNA replication remains elusive, as it 
does not appear to phosphorylate any of the known components of the viral replication 
machinery (Boyle and Traktman, 2004 and P.T., unpublished data). However, since a B1 
defect can be complemented by expression of hVRK1 from the viral genome (Boyle and 
Traktman, 2004) and since both hVRK1 and B1 can efficiently phosphorylate BAF in vitro 
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(Nichols et al., 2006), it seemed plausible to propose an important role for B1-mediated 
phosphorylation of BAF during vaccinia infection. 
 
Results 
 
BAF Phosphorylation Increases during Vaccinia Infection 
To first investigate whether BAF is phosphorylated during poxviral infections, we ex-
pressed BAF as a 3X-FLAG fusion protein, either transiently in U2OS or BSC40 cells, or 
stably by engineering a novel derivative of tetracycline-inducible 293 cells (293:BAF). In 
uninfected cells, BAF appears as two closely migrating forms in immunoblot analysis (fig. 
1A). Only the more slowly migrating form is radiolabeled when transfected cells are incu-
bated in the presence of 32PPi, indicating that the posttranslational modification induces a 
shift in BAF’s electrophoretic mobility (fig. 1A, lane 2, U2OS lysates; Nichols et al., 2006). 
When all three cell lines were infected with wildtype (wt) vaccinia virus, the proportion of 
BAF present as the phosphorylated form increased, as did the intensity of the 32P signal in 
the labeled U2OS cells (lane 3). To examine whether this phosphorylation was indeed me-
diated by the virally encoded B1 kinase, we utilized the ts2 temperature sensitive mutant, 
which has a point mutation in the B1 locus that greatly diminishes both the catalytic activ-
ity and stability of the protein (Rempel and Traktman, 1992). Importantly, the phosphory-
lation of BAF failed to increase during nonpermissive infections with ts2 (fig. 1A, compare 
lanes 2 and 4), supporting the conclusion that B1 phosphorylates BAF in vivo. To confirm 
that the lack of BAF phosphorylation under these conditions was a direct consequence of 
B1’s inactivation, rather than an indirect effect of the subsequent arrest of the viral life cy-
cle, we mimicked the latter by performing infections with wt virus in the presence of cyto-
sine arabinoside (araC). Under these circumstances, in which B1 is active but post-
replicative events are blocked (Oda and Joklik, 1967), the increased phosphorylation of 
cytoplasmic (soluble) BAF was still observed (fig. 1B, compare lanes 1 and 3 with 5 and 7). 
Finally, we monitored the phosphorylation status of BAF following infection with 
ts2/hVrk1, a derivative of ts2 that has been complemented by the insertion of the human 
Vrk1 cDNA (Boyle and Traktman, 2004). Following infection with ts2/hVrk1, the propor-
tion of BAF in the phosphorylated form also increased (fig. 1A, compare lanes 5 and 3). 
To verify that our observations using FLAG-tagged BAF were also observed with en-
dogenous BAF, we examined the phosphorylation of both the endogenous and exogenous 
BAF proteins during vaccinia infections. This was accomplished using an antibody that we 
generated which specifically recognizes BAF molecules containing a phosphate moiety on 
Ser4, the site preferentially modified by B1 and VRK1 in vitro and in vivo (Nichols et al., 
2006) (see fig. S1). Indeed both FLAG-BAF and endogenous BAF showed a robust shift to 
the phosphorylated form soon after infection with wt virus (fig. 1C, compare lanes 1 and 
2), but not after ts2 infection (compare lanes 2 and 5). More specifically, quantitation of 
endogenous BAF modification at 2 hpi revealed a 10-fold greater phosphorylation during 
wt versus ts2 infection. These data confirm that, in the context of viral infection, expression 
of B1 (or VRK1) from the cytoplasmic viral genome leads to an increase in the fraction of 
BAF that is phosphorylated. 
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Figure 1. BAF Is Phosphorylated during Vaccinia Infection in a B1-Dependent Manner. 
BSC40, U2OS, and 293:BAF cells were engineered to express FLAG-BAF either through 
transient transfection (BSC40 and U2OS) or TET induction (293:BAF cells). Cells were left 
uninfected or infected for 5 hr with wild-type vaccinia virus, ts2, or ts2/hVrk1 at 39.7°C, as 
shown (MOI = 10). 
(A) Lysates were prepared from all cells using 0.5% Triton X-100. The U2OS cells were 
metabolically labeled with 32PPi for 5 hr prior to harvest, and the BAF was retrieved by 
immunoprecipitation with rabbit α-FLAG antibody. These immunoprecipitates, and the 
soluble lysates prepared from the other cell lines, were resolved by SDS-PAGE and either 
subjected to immunoblot analysis with the M2 α-FLAG antibody or visualized by autora-
diography (top panel only). Open and filled triangles indicate unphosphorylated and 
phosphorylated BAF, respectively. 
(B) BSC40 cells expressing FLAG-BAF were infected ±20 µM AraC. Lysates were pre-
pared in the presence of 0.5% Triton X-100 as in (A), and the BAF protein in both the 
soluble (S) and insoluble (P) fraction was visualized by immunoblot analysis. 
(C) 293:BAF whole cell lysates were harvested at the indicated time postinfection. En-
dogenous BAF and FLAG-BAF were detected either with an antibody specific to the N 
terminus of BAF or M2 antibody, respectively. Phosphorylated endogenous BAF and 
phosphorylated FLAG-BAF were detected using an antibody raised against a BAF pep-
tide phosphorylated at Ser-4. Vaccinia I3 was detected using α-I3 serum. 
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BAF Associates with Viral DNA Replication Sites in the Absence of the B1 Kinase 
We next sought to understand how phosphorylation of BAF might be important during 
vaccinia infection. In light of the fact that (1) the ability of BAF to bind DNA is strongly 
inhibited by phosphorylation, and (2) a catalytically active B1 kinase is needed for ongoing 
viral DNA replication, we hypothesized that unphosphorylated, cytoplasmic BAF would 
bind to vaccinia DNA upon its release from the viral core into the cytoplasm. This uncoat-
ing event occurs after the phase of early viral gene expression and enables DNA replication 
to commence. Once BAF would have access to the released genome, its ability to cross-
bridge DNA (Bradley et al., 2005; Suzuki and Craigie, 2002) might, in essence, lead to a 
sequestering of the genome that would block replication. This model would be consistent 
with the observation that catalytically active hVRK1, but not an inactive variant, rescues 
the replication defect of ts2 (Boyle and Traktman, 2004). Based on this hypothesis, we first 
predicted that BAF would be recruited to viral DNA replication sites during a nonpermis-
sive ts2 infection (39.7°C), but not during an infection with wt virus or with ts2 at the per-
missive temperature (31.5°C). 293 cells stably expressing FLAG-BAF were utilized to study 
BAF localization, because the anti-BAF antibodies that are available cannot be used to de-
tect endogenous BAF by immunofluorescence. FLAG-BAF was found in both the nucleus 
and the cytoplasm (fig. 2A), as has been previously observed for the endogenous protein 
(Haraguchi et al., 2001; Segura-Totten et al., 2002). These cells were then infected with wt 
vaccinia virus and the intracellular localization of FLAG-BAF was assessed. At 9 hpi, the 
protein was present throughout the cell (fig. 2C), exhibiting no colocalization with, or con-
centration at, the cytoplasmic sites of viral replication, which were visualized both by DAPI 
staining (fig. 2E) and with an antibody specific for the viral single strand DNA-binding pro-
tein (I3) (arrowheads, fig. 2D) (Rochester and Traktman, 1998). We next monitored the lo-
calization of BAF following infection with ts2 for 9 hr at the permissive temperature; under 
these conditions, BAF retains a diffuse localization in the great majority of cells (Panel F). 
However, in keeping with the fact that the phenotype of ts2 is not fully wild-type even at 
the permissive temperature (Rempel et al., 1990), we did observe colocalization of BAF 
with 10%–15% of the replication sites (arrows, fig. 2F–2H). To examine whether BAF would 
consistently localize with foci of viral DNA during nonpermissive ts2 infections, we per-
formed the initial 7 hr of infection at the permissive temperature so that replication would 
begin and macromolecular sites of DNA accumulation would form, and then shifted the 
cultures to the nonpermissive temperature for an addition 2 hr. Importantly, this “shiftup” 
protocol leads to the cessation of viral DNA synthesis within 30 min (Rempel and 
Traktman, 1992). When these cultures were examined, we saw a striking colocalization of 
BAF with ~90%of the viral DNA replication sites (arrows in the three examples shown in 
fig. 2I–2Q). Together, these data are consistent with a model in which BAF remains diffuse 
during wt infection, when it is fully phosphorylated by B1 and hence does not bind to viral 
DNA. In contrast, under conditions where active B1 is lacking, the vast majority of BAF 
remains unphosphorylated and therefore binds to viral DNA replication complexes. 
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Figure 2. BAF Colocalizes with Vaccinia DNA Replication Sites in the Absence of Functional B1 
but Not during Infections with WT Virus 
293:BAF cells were induced to express FLAG-BAF and left uninfected (A and B) or then 
infected (MOI = 5) with wt virus at 31.5°C for 7 hr followed by a shift to 39.7°C for an 
additional 2 hr (C–E), ts2 at 31.5°C (F–H), or ts2 at 31.5°C for 7 hr followed by a shift to 
39.7°C for an additional 2 hr (3 examples in I–K, L–N, and O–Q). At 9 hpi, cells were fixed 
and proteins visualized with M2 α-FLAG and α-I3 primary antibodies followed by fluo-
rescent secondary antibodies. Arrowheads indicate viral DNA replication sites that ex-
hibit no BAF colocalization, whereas arrows indicate replication sites that do show BAF 
colocalization. DNA was visualized using DAPI. Scale bars represent 50 mm in (A and B) 
and 25 µm in (C–Q). 
 
We next examined the rate of DNA accumulation in these same 293:BAF cells using the 
identical ‘‘shift up’’ protocol. This experiment has previously been performed in L929 cells, 
in which a shift to the nonpermissive temperature during ts2 infection results in a precip-
itous drop in the rate of DNA replication while no change is observed during wt vaccinia 
infection (Rempel and Traktman, 1992). To determine whether this also occurs in 293:BAF 
cells and would coincide with the relocalization of BAF to sites of viral DNA replication, 
we infected 293:BAF cells at 31.5°C with wt virus and ts2. The amount of viral DNA was 
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assessed at 3, 7, 9, and 12 hpi by dot blot hybridization; we examined infections which 
were either performed entirely at 31.5°C or shifted to 39.7°C at 7 hpi, a protocol which 
mirrors the procedure used in the immunofluorescence studies (fig. 2). We observed that 
during wt infection, there was no difference in the rate of DNA synthesis in infections per-
formed at 31.5°C versus those shifted to 39.7°C (fig. 3A, solid black versus dashed black 
lines). In contrast, as has been seen in other cell lines, the rate of DNA synthesis during ts2 
infections was reduced overall compared to that seen with wt virus (compare solid gray 
with solid black lines). Moreover, the rate of DNA synthesis slowed significantly after the 
cultures were shifted to 39.7°C (compare solid gray versus dashed gray lines). These data 
demonstrate that the relocalization of BAF to the sites of viral DNA accumulation which 
is seen when ts2 infections are shifted to 39.7°C (fig. 2) is correlated with an inhibition of 
further DNA replication. 
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Figure 3. BAF Can Inhibit DNA Replication In Vivo and In Vitro 
(A and B) Relative rates of viral DNA accumulation were assessed by dot blot hybridiza-
tion of cell lysates following wt and ts2 infection. In (A), infections were initiated in 
293:BAF cells at 31.5°C; infected cells were either left at that temperature throughout the 
experiment or shifted to 39.7°C at 7 hpi. In (B), both 293:CAT and 293:BAF cells were used 
and all infections were shifted to 39.7°C at 7 hpi. Duplicate experiments were performed 
and analyzed in triplicate; the average values are shown, with standard errors indicated. 
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(C) Nick translation reactions were preincubated with unphosphorylated or phosphor-
ylated BAF prior to the addition of E. coli Pol I for 1 hr, and the incorporation of radio-
labeled dNTPs into DNA was measured. The average of two experiments is shown as 
percent efficiency compared to reactions with no BAF with standard errors shown. 
 
Increased BAF Levels Correlate with Decreased DNA Synthesis In Vivo and In Vitro 
If BAF is capable of inhibiting viral DNA synthesis, an inverse correlation should exist 
between the abundance of BAF in the cytoplasm and the levels of viral DNA that are pro-
duced. To test this prediction, we compared DNA accumulation during infections per-
formed with wt virus or ts2 in the control 293:CAT cell line and the 293:BAF cell line, each 
of which had been grown in 1 µg/ml tetracycline. In all cases, infections were performed 
at 31.5°C for 7 hr, and then shifted to 39.7°C. For both viruses, BAF overexpression corre-
lated with a reduction of the amount of viral DNA that had accumulated at each time point 
assayed (fig. 3B). At 12 hpi, the amount of DNA accumulated in 293:BAF cells infected with 
wt virus (black solid line) was 70% of that seen in 293:CAT cells (gray solid line). The im-
pact of BAF overexpression on ts2 was more dramatic: the amount of DNA seen in 293:BAF 
cells at 12 hpi was only 33% of that found in the 293:CAT cells (compare the black and gray 
dashed lines). 
We hypothesized that the recruitment of BAF to the sites of DNA synthesis and the 
subsequent inhibition of DNA replication was mediated by direct binding of nonphos-
phorylated BAF to viral DNA. Although several studies characterizing the BAF-DNA in-
teraction have been published, the implications of this interaction on transcription or 
replication of the coated DNA have not been addressed. To assess whether BAF-bound 
DNA could still serve as a replication template, E. coli DNA polymerase I and plasmid 
DNA were incubated in standard nick translation reactions in the presence of increasing 
concentrations of either unphosphorylated or phosphorylated BAF. When increasing 
amounts of unphosphorylated BAF were added to the DNA template for 10 min prior to 
the addition of DNA Polymerase I, there was a sharp, dose-dependent decrease in the 
amount of nascent DNA synthesis (fig. 3C). However, when the same experiment was per-
formed using a BAF preparation that had been stoichiometrically phosphorylated by the 
B1 kinase, DNA synthesis proceeded unabated. These data clearly demonstrate that, when 
it is not phosphorylated, the direct interaction of BAF with DNA can act as a potent inhib-
itor of DNA synthesis. 
 
Overexpression of BAF Reduces Viral Yield; shRNA-Mediated Depletion of BAF Rescues 
the Temperature-Sensitive Phenotype of ts2 
Since overexpression of BAF reduces viral DNA replication, it seemed reasonable to pre-
dict that it might also affect virus production, and so exacerbate the temperature sensitivity 
of ts2. 293 cells induced to express FLAG-BAF or the chloramphenicol acetyltransferase 
(CAT) protein (control) were infected with wt virus or ts2 at both 31.5°C and 39.7°C, and 
the yield of infectious virus was determined at 24 hpi (fig. 4A). Under the conditions used, 
this induction resulted in a 4- to 5-fold overexpression of FLAG-BAF versus endogenous 
BAF, as determined by quantitative immunoblot analysis (representative experiment 
shown in fig. 4B). While wt vaccinia virus produced comparable yields in 293:CAT cells at 
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both temperatures, ~3-fold less progeny were produced in 293:BAF at 39.7°C than at 
31.5°C, indicating that overexpression of BAF might be somewhat inhibitory even in the 
presence of an active B1 kinase. This conclusion is supported by our finding (see fig. 3) that 
the levels of DNA synthesized by wt virus were reduced when BAF was overexpressed. 
The expected temperature sensitivity of ts2 was evident in the control 293:CAT cell line, in 
which the yield of virus produced at 39.7°C was only 6.5% of that produced at 31.5°C; this 
phenotype is comparable to what has been previously observed in BSC40 cells (Boyle and 
Traktman, 2004). Even at the permissive temperature, the viral yield in the cells overex-
pressing BAF was 3-fold less than what was seen in the control cells. The temperature sen-
sitivity of the virus was also exacerbated: in the 293:BAF cells, the yield of virus produced 
at 39.7°C was only 1.6% of that produced at 31.5°C. Furthermore, when DNA replication 
was monitored in 293:BAF cells infected at 39.7°C, the levels of DNA that accumulated in 
ts2-infected cells was only 7% of that seen in wt-infected cells (fig. S2). These data indicate 
that when the B1 kinase is impaired and the levels of BAF are elevated, completion of a 
productive infectious cycle is impaired. 
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Figure 4. Overexpression of Wild-Type BAF from the Cellular Genome Exacerbates the ts2 Phe-
notype, while shRNA-Directed Depletion of BAF Rescues the ts2 Phenotype 
(A and B) 293:CAT or 293:BAF cells were grown in media containing tetracycline for 6 
days and either harvested for immunoblot analysis using a rabbit αBAF antibody (B) or 
plated in fresh media containing TET and then infected with wt virus or ts2 (MOI = 5) at 
31.5 or 39.7°C (noted as 32 and 40°C for simplicity) (A). All infections were harvested at 
24 hpi and viral yield was determined. For each cell line, the yield of ts2 obtained at 39.7°C 
is expressed as a percent of that obtained at 31.5°C. 
(C and D) 293 cells stably expressing shRNAs for 96 hr were either (C) harvested for 
immunoblot analysis using a rabbit αBAF antibody (total protein visualized using Coo-
massie) or (D) infected with wt virus or ts2 for 24 hr as described above. All data represent 
viral yields from infections titrated in duplicate or triplicate, with standard errors shown. 
 
If unphosphorylated BAF represents a barrier to infection, then its absence should res-
cue the temperature-sensitivity of ts2 infections. We therefore generated replication- 
incompetent lentiviruses that would allow shRNA-mediated depletion of endogenous 
BAF. Cells were treated with a control lentivirus, a lentivirus encoding a scrambled shRNA 
with no target specificity, or a lentivirus encoding an shRNA whose sequence is known to 
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target BAF efficiently (Jacque and Stevenson, 2006). Using the latter lentivirus, we consist-
ently observed an ~85% decrease in the levels of endogenous BAF at 96 hpi (fig. 4C). After 
this pretreatment, each of the cultures was infected with wt vaccinia virus or ts2 at both 
31.5°C and 39.7°C, and the yield of viral progeny was determined after 24 hr (fig. 4D). Wt 
virus produced comparable viral yields under all conditions. The temperature sensitivity 
of ts2 was clearly observed in both of the control cell lines, with the yield of virus obtained 
at 39.7°C being <8% of that produced at the permissive temperature. However, in the 
shBAF-treated cells, the yield of virus produced by ts2 at the nonpermissive temperature 
was dramatically increased to 41% of that produced at the permissive temperature. Stated 
another way, in the context of a defective B1 kinase, a 6.7-fold reduction in BAF levels led 
to a 14-fold increased in virus production at 39.7°C. Clearly, depletion of BAF leads to a 
near reversal in the temperature-sensitive defect of ts2. 
 
Unphosphorylatable BAF Cannot Be Expressed from the Viral Genome 
Our final prediction was that, if depletion or phosphorylation of BAF is a prerequisite for 
efficient viral DNA replication, then the cytoplasmic expression of a nonphosphorylatable 
variant of BAF should inhibit viral replication. We previously identified such a variant 
during our characterization of B1- and VRK1-mediated phosphorylation of BAF (Nichols 
et al., 2006). The BAF-MAAAQ protein, in which the B1 target sites Thr-2, Thr-3, and Ser-
4 have been replaced with alanine, is no longer modified by B1 (or hVRK1) and retains 
DNA-binding activity in the presence of the kinase. These N-terminal amino acid substi-
tutions prevent the phosphorylation of BAF without affecting its intrinsic DNA-binding 
activity or its stability in vivo. To compare the impact of wt BAF and BAF-MAAAQ on the 
vaccinia life cycle, we attempted to generate viral recombinants expressing these proteins. 
The pJS4-RFP plasmid (shown in fig. 5A), contains 2 divergent vaccinia promoters, one of 
which was used to drive the expression of RFP (red fluorescent protein), and the second to 
express the relevant BAF protein. Sequences derived from each half of the vaccinia TK 
locus flank this cassette and enable its stable insertion into the viral genome via homolo-
gous recombination. This recombinational insertion leads to the inactivation of the TK lo-
cus, which in turn renders the virus resistant to bromodeoxyuridine (BrdU). 
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Figure 5. A Nonphosphorylatable Derivative of BAF Is Lethal for Viral Infection When Expressed 
from the Viral Genome 
(A and B) Expression of BAF from the viral genome: Linearized pJS4 – RFP, RFP + BAF, 
and RFP + MAAAQ plasmid DNA was introduced into BSC40 cells previously infected 
with wt vaccinia virus (MOI = 0.03), and recombinational insertion of the transcriptional 
cassette into the viral TK locus was allowed to proceed during 2 days of incubation. One 
passage was then performed in human TK– cells ± BrdU to select for TK-deficient virus. 
The viral yield was then determined by titration on BSC40 cells, and red fluorescent 
plaques were counted to determine the number of TK– viruses expressing RFP, and by 
inference, BAF or BAF-MAAAQ. The frequency of red plaques obtained in each of the 
three experiments was compared in pairwise fashion, and the difference between each 
was found to be significant using a Fisher’s exact test (p < 0.0001). 
 
Cells were infected with wt virus and transfected with linearized plasmid, the expres-
sion of which was verified by RFP fluorescence in the initial transfection (data not shown). 
The viral yield from these infections/transfections was passaged in the absence or presence 
of BrdU (to amplify all the virus present or to select for TK– viruses, respectively). In the 
absence of BrdU selection, all three stocks contained a similar viral titer (fig. 5B). The total 
viral yield decreased markedly following BrdU selection, but equivalent titers were ob-
tained from infections/transfections involving plasmids expressing RFP alone or RFP and 
wt BAF. Moreover, a significant fraction of these TK– plaques were red, confirming that 
their BrdU-resistance was a result of integration of the RFP (or RFP    4BAF)-expressing 
cassette rather than the acquisition of random mutations that had inactivated the TK locus. 
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Viruses expressing wt BAF were isolated at a lower frequency than those expressing RFP 
alone, suggesting that constitutive expression of BAF may render these viruses somewhat 
less fit, although this possibility has not been explored further. Nonetheless these viruses 
could be readily generated, and the expression of BAF from their genome was verified by 
immunoblot analysis (fig. S3). We also attempted to insert the RFP or RFP    BAF cassette 
into the ts2 genome at 31.5°C. While ts2 viruses expressing RFP alone were readily isolated, 
red plaques that were presumed to contain the RFP    BAF cassette were ~25% of the size 
of nonred plaques and could only be passaged for two infectious cycles (data not shown) 
before infectivity was lost. Presumably, even at the permissive temperature, the compro-
mised B1 protein produced by ts2 was insufficient to overcome the repression mediated 
by overexpression of BAF from the viral genome. 
Our attempts to isolate wt viruses containing the RFP    BAF MAAAQ cassette pro-
ceeded far differently than had our successful efforts to generate viruses expressing RFP 
or RFP + wt BAF (see above). Only 10% as much virus was recovered after passage of the 
progeny obtained from the infection/transfection in the presence of BrdU, and none (0 of 
332) of these TK– plaques were red (fig. 5B). The inability to obtain recombinants express-
ing BAF MAAAQ strongly supports the conclusion that the expression of a nonphosphor-
ylatable derivative of BAF in the cytoplasm is lethal for the virus, presumably as a result 
of sequestration of the viral genome. 
 
Discussion 
 
The cellular BAF protein is known to play important roles in regulating nuclear architec-
ture during the cell cycle via interactions with DNA and inner nuclear membrane proteins 
containing LEM domains. BAF’s closest relative, BAF-like protein (BAF-L) has 40% homo-
log to BAF, but appears unable to bind DNA or LEM domains, indicating that these are 
attributes unique to BAF (Tifft et al., 2006). In addition to its nuclear localization, BAF has 
been observed in the cytoplasm of interphase cells (Segura-Totten and Wilson, 2004), although 
it has been unclear how this pool of BAF contributes to cellular function. However, early 
in our studies we made the observation that transiently expressed GFP-BAF could be seen 
to colocalize with transfected DNA, which formed DAPI-positive speckles in the cyto-
plasm. These data suggested that cytoplasmic BAF can, and does, recognize and bind to 
DNA (M.S.W and P.T., unpublished data). 
It has become clear that BAF’s functions within the cell are regulated by phosphoryla-
tion. We have shown that the nuclear VRK1 kinase phosphorylates BAF in vitro and in 
mammalian cell culture, regulating its DNA-binding activity, its interaction with LEM do-
mains, and its intracellular localization (Bengtsson and Wilson, 2006; Nichols et al., 2006). 
The interplay of VRK and BAF has recently been found to be operative in C. elegans as well, 
where it appears to regulate the association of BAF with chromatin during nuclear reas-
sembly at the end of mitosis (Gorjanacz et al., 2007). Interestingly, the VRK kinases are 
closely related to the B1 kinase encoded by the vast majority of poxviruses, which are com-
plex DNA viruses that replicate exclusively in the cytoplasm of infected cells. The fact that 
VRK1 can complement the replication defect of a B1 mutant of vaccinia virus indicates that 
the viral and cellular kinases share functional as well as structural similarity, and indeed 
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B1 retains the ability to repress BAF’s DNA-binding capability in a manner that is nearly 
indistinguishable from VRK (Nichols et al., 2006). 
Based on these observations, we postulated that the DNA-binding activity of cytoplas-
mic BAF might represent a novel, intrinsic host defense against the expression of foreign 
DNA. Because VRK1 shows a nuclear localization, and is not available to phosphorylate 
cytoplasmic BAF (Lopez-Borges and Lazo, 2000; Nichols and Traktman, 2004), we rea-
soned that the viral B1 kinase had evolved to target the same residues on BAF which would 
be targeted VRK1. B1 is both encapsidated in vaccinia virions and expressed immediately 
upon infection (Banham and Smith, 1992; Lin et al., 1992; Rempel and Traktman, 1992), 
and is therefore poised to phosphorylate BAF and block its ability to bind to the viral ge-
nome as it is released from the core, allowing viral DNA replication to proceed efficiently. 
In this report, we have demonstrated that endogenous BAF is indeed phosphorylated 
in a B1-dependent manner during vaccinia virus infections, as is a stably expressed 
epitope-tagged BAF. When active B1 is present, this epitope-tagged BAF is found through-
out the cell; however, when infection proceeds in the presence of an impaired B1 kinase, 
BAF relocalizes rapidly and extensively to the sites at which viral DNA has accumulated. 
This localization correlates with a diminution of further viral DNA replication. Overex-
pression of BAF exacerbates the temperature-sensitive phenotype of the ts2 mutant, greatly 
reducing DNA synthesis and further diminishing virus production at the nonpermissive 
temperature. Indeed, the overexpression of BAF has a dampening effect on viral DNA rep-
lication and the production of infectious progeny even in the presence of a wild-type B1 
kinase. Our hypothesis that the association of BAF with viral DNA in vivo would impair 
replication, and perhaps transcription, is supported by our demonstration that BAF inhib-
its DNA synthesis in vitro in a dose-dependent manner. Phosphorylated BAF, which lacks 
DNA-binding activity, has no such effect. Finally, while it remains possible that BAF also 
inhibits the activity of vaccinia proteins in vivo through direct protein:protein interactions, 
our in vitro studies utilized no viral proteins, demonstrating that BAF’s repressive ability 
relies only on its interaction with DNA. 
To complement our analysis of the impact of BAF overexpression, we utilized shRNA 
technology to assess the impact of BAF depletion. Depletion of BAF had a striking effect, 
leading to a near reversal of the temperature-sensitive phenotype of the ts2 mutant. These 
data imply that the primary and most vital role played by the B1 kinase during the vaccinia 
virus life cycle is to overcome the repressive effect of BAF. 
As another test of whether phosphorylation of BAF was as vital as it appeared to be for 
efficient viral replication, we attempted to generate viral recombinants expressing wt BAF 
or a nonphosphorylatable derivative of BAF. While viruses expressing BAF were readily 
isolated, we were unable to isolate any recombinants expressing the BAF-MAAAQ deriv-
ative. The expression of nonphosphorylatable BAF from the viral genome, where it is trans-
lated in close proximity to the viral genome, is in fact lethal to the virus. 
Cells have numerous mechanisms at their disposal to detect invaders, but viruses have 
evolved equally numerous countermeasures that enable them to direct successful infec-
tions. It is the efficiency with which these countermeasures work that often defines the host 
range of a particular virus. Interestingly, molluscum contagiosum virus (MCV) is the only 
poxvirus that lacks a B1 homolog, and this virus exhibits a very narrow host range. It is 
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only able to replicate in the stratified epithelium of human skin, and has not been success-
fully passaged in any cell culture system (Birthistle and Carrington, 1997). We speculate 
that the keratinocyte layer that is permissive for MCV infection may either have very low 
levels of cytoplasmic BAF or contain a cytoplasmic pool of a kinase (like VRK) that can 
phosphorylate and neutralize BAF. Alternatively, MCV may encode an as yet unknown 
protein that overcomes BAF via a distinct mechanism. 
This duel between BAF and B1 is a newly identified example of the intricate interplay 
between pathogens and their hosts. Among the most well-characterized mediators of this 
innate surveillance against infection are the toll-like receptors, which are capable of re-
sponding to a variety of foreign molecules including DNA and RNA (Vasselon and Det-
mers, 2002). However, the absence of TLRs from most nonimmune cells has stimulated 
speculation that other sensors of foreign nucleic acid must exist (Ishii et al., 2006; Stetson 
and Medzhitov, 2006; Wagner and Bauer, 2006). Indeed, the elucidation that the RNA hel-
icase RIG-I can act as a cytoplasmic RNA sensor, and indeed can trigger the downstream 
activation of host response genes indicates that this is true (Meylan and Tschopp, 2006). 
Because BAF is a highly conserved protein (fig. S4) found in all eukaryotic dividing cells 
that have been tested (Mansharamani et al., 2003) and because it binds DNA avidly and 
without regard to sequence specificity, our findings raise the possibility that BAF might be 
a central component of a widespread host defense which recognizes and silences foreign 
DNA. It will be of significant interest to determine whether, subsequent to its binding to 
foreign DNA, BAF may function like RIG-I and contribute to a signaling cascade that alerts 
cells of a possible infection. 
 
Experimental Procedures 
 
Cloning and Production of Stable Cell Lines 
pcDNA5/FRT/TO/3XFLAG-BAF was constructed by amplifying the Baf alleles from 
p3XFLAG-BAF (Nichols et al., 2006) with the primers FLAGBAF-UPBam (5′-GAGGGTAC 
CGGATCCGCACCATGGACTACAAA-3′) and BAF-DN. This places a BamHI sequence 
(underlined) both upstream and downstream of the ORF, which were used to clone into 
the BamHI site present in the pcDNA5/FRT/TO. 
Stable integration of CAT and 3XFLAG-BAF in 293 cells was accomplished using the 
Flp-In System (Invitrogen, Carlsbad, California), which employs 293 Trex cells (Invitrogen) 
containing two stably integrated plasmids. The first plasmid pcDNA6/TR constituitively 
expresses TetR; a single integrated copy of the second plasmid pFRT/lacZeo contains the 
yeast FRT recombination site. These cells were co-transfected with pcDNA5/FRT/TO-CAT 
or –3XFLAG-BAF and pOG44, a plasmid expressing the S. cerevisiae Flp recombinase. Ex-
pression of Flp mediates a single recombination event between the FRT site in pcDNA5/ 
FRT/TO plasmids and the FRT site integrated into the 293 genome, thus ensuring that the 
resulting 293:CAT and 293:BAF cells express each of their exogenous genes from a single 
copy at the same genetic locus. Properly targeted cells are selected by growth in 100 mg/ml 
hygromycin and 15 mg/ml blasticidin; expression is uniform because all cells express the 
protein from a single copy of a cDNA inserted at the same genomic locus under the regu-
lation of the same promoter. 
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Cloning and Production of Recombinant Viruses 
pJS4-RFP-BAF and -MAAAQ were constructed by amplifying the Baf alleles from 
p3XFLAG-BAF and p3XFLAG-BAF-MAAAQ with the primers FLAG-BAF-UPXho (5′-
CAGCTCGAGGCCACCATGGACTACAAAGACC-3′) and BAF-DN (5′-GCTGAATTC 
GGATCCTCACAAGAAGGCG-3′). This places a XhoI site (italics) upstream and a BamHI 
site (underlined) downstream of the ORF, which were used to clone into the corresponding 
sites present in pJS4-RFP (Chakrabarti et al., 1997). 
 
Virus and Infections 
 
Virus Preparation 
Wild-type vaccinia virus (WR strain), ts2, and ts2:hVrk1 (Boyle and Traktman, 2004) were 
grown in BSC40 cells at 37°C or 31.5°C, respectively. Viral stocks were prepared from cy-
toplasmic lysates of infected cells by ultracentrifugation through 36% sucrose and then 
titrated on BSC40 cells. During infections, 31.5 and 39.7°C were used as the permissive and 
nonpermissive temperatures, respectively, and are referred to in figures as 32 and 40°C. 
 
24 Hr Yield 
Confluent 35 mm-diameter dishes of 293:CAT or 293:BAF cells were infected at an MOI of 
5 and maintained at 31.5 or 39.7°C. Cells were harvested at 24 hpi in 1 mM Tris (pH 9.0). 
Virus yields were assessed by plaque assays performed on BSC40 cells at 31.5°C. Three 
separate experiments were performed, and each was titrated in triplicate; the average 
value is shown with standard errors indicated. 
 
Immunofluorescence 
293:BAF cells were grown in 1 µg/ml tetracycline for 3 days prior to plating on chamber 
slides (Lab-Tek, Naperville, Illinois) 48 hr before infection and/or fixation. Infections were 
performed at an MOI = 5. At 9 hpi, cells were fixed in 4% PFA, 4% sucrose in phosphate-
buffered saline (PBS; 140 mM NaCl, 2 mM KCL, 10 mM Na2HPO4, 1 mM KH2PO4, [pH 7.4]) 
at room temperature for 15 min, permeabilized with 0.2% Triton X-100 in PBS for 5 min at 
room temperature, and then blocked in PBS/5% BSA for 30 min. Cells were then incubated 
with mouse α-FLAG M2 antibody (Sigma) and rabbit α-I3, both at a dilution of 1:400 in 
PBS/1% BSA. This was followed by Alexa-fluor 594-conjugated goat α-mouse and Alex-
fluor 488-conjugated goat α-rabbit-488 (Molecular Probes) at 1:500 in PBS/1% BSA. DNA 
was stained with DAPI. Proteins were observed by indirect fluorescence on a Nikon 
Eclipse TE2000-U microscope (Melville, NY). Images were pseudocolored using Meta-
Morph software (Sunnyvale, California) and labeled using Canvas 8 (Deneba Systems, Mi-
ami, Florida). 
 
Cell Culture and Reagents 
Human thymidine kinase-negative 143B osteosarcoma cells (TK–) and African green mon-
key BSC40 kidney epithelial cells were maintained as monolayers in DMEM, supple-
mented with 5% fetal bovine serum (FBS; GIBCO/Invitrogen, Carlsbad, California) in the 
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presence of 5% CO2. Human osteosarcoma U2OS cells were maintained in DMEM with 
10% FBS. Flp-In Trex 293 HEK cells were obtained from Invitrogen and grown in DMEM 
with 10% FBS, 50 mg/ml hygromycin, and 7.5µg/ml blasticidin after they had been stably 
transfected with pcDNA5/FRT/TO-CAT or –3XFLAG-BAF. The following plasmids were 
used in this study: p3XFLAG-BAF (Nichols et al., 2006), and pcDNA5/ FRT/TO (Invitro-
gen). pJS4 was generously provided by B. Moss (NIAID, Bethesda, Maryland); the pJS4: 
RFP derivative was previously generated in our laboratory by Jason Mercer (unpublished 
data). 
 
Cell Lysis and Immunoblotting 
Approximately 1 × 106 U2OS or BSC40 were transiently transfected with 1 µg of p3XFLAG-
BAF or empty vector using Lipofectamine 2000. 1 × 106 293:BAF cells were induced to ex-
press the relevant protein with 1 µg/ml tetracycline. At 16 hr posttransfection or postinduc-
tion, the cells were infected with wild-type virus, ts2, or ts2/hVrk1 and at 5 hpi were 
resuspended in ice-cold fractionation buffer (20 mM Tris pH 7.4, 5 mM MgCl2, 5 mM DTT, 
150 mM KCl, and 0.5% Triton X-100) containing 1 mM NaF, 1 mM sodium orthovanadate, 
40 mM β-glycerol phosphate, 1 µg/ml leupeptin, 1 µg/ml pepstatin, and 1 mM PMSF. After 
10 min of incubation on ice, sucrose was added to 10%, and the insoluble fraction was 
retrieved by centrifugation at 1000 × g for 10 min. The supernatant was resolved by SDS-
PAGE and subjected to immunoblot analysis with α-FLAG M2 antibody. When indicated, 
U2OS cells were radiolabeled by replacing the media with phosphate-free DMEM (MP Bi-
omedical, Irvine, California) supplemented with 100 µCi/ml 32PPi from 20 to 24 hr post-
transfection, and FLAG-BAF was then retrieved from the soluble fraction of radiolabeled 
extracts using rabbit α-FLAG sepharose, washed, and eluted in SDS sample buffer before 
analysis by immunoblot and autoradiography. 
 
Antibodies 
Antiserum specific for vaccinia single-stranded binding protein I3 has been described 
(Rochester and Traktman, 1998). Rabbit a-BAF antibody recognizing total BAF was gener-
ously provided by Dr. Katherine Wilson (Johns Hopkins University, Baltimore, Maryland). 
An antibody specific for BAF modified by phosphorylated on Ser-4 was generated in rab-
bits by Bethyl Laboratories, Inc. (Montgomery, Texas). Antibody was raised against the 
KLH-conjugated peptide MTT(pS)QKHRDFC, and phosphospecific antibody was isolated 
from serum by sequential negative and positive affinity purification. 
 
Production and Use of shRNA Lentiviruses 
The pLL3.7-shBAF construct was produced by annealing the primers shBAF-UP (5′-
TGGCCTATGTTGTCCTTGGCTTCAAGAGAGCCAAGGACAACATAGGCCTTTTT 
GGAAAC-3′) and shBAF-DN (5′-TCGAGTTTCCAAAAAGGCCTATGTTGT CCTGGCTC 
TCTTGAAGCCAAGGAC AACATAGGCCA-3′) and cloning them into the HpaI and XhoI 
sites of pLL3.7/Puro (Rubinson et al., 2003). The pLL3.7-Scram construct was produced by 
annealing shScram-UP (5′-TCAGTCGCGTTTGCGA CTGGTTCAAGAGACCAGT CGCA 
AACGCGACTGTTTTTGGAAAC-3′) and shScram-DN (5′-TCGAGTTTCCAAAAACAG-
TCGCGTTTGCGACTGGTCTCTTGAACCAGTCGCAAACGCGACTGA-3′) and cloning 
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the product into the HpaI and XhoI sites of pLL3.7/Puro. Lentiviruses expressing shRNAs 
were produced in 293T cells following transfection with either pLL3.7, pLL3.7-shBAF, or 
pLL3.7-shScram in combination with pMD2.G, pRSV REV, and pMDLg/pRRE encoding 
the VSV-G, Rev, and Gag/Pol genes, respectively. At 16 hr post transfection, fresh media 
was added to cells. At 48 hr post transfection, the media containing recombinant virus was 
harvested, polybrene was added to 8 µg/ml, and stocks were aliquoted for storage at –
80°C. 
To inhibit BAF expression, 293:CAT cells were infected with lentivirus containing 
pLL3.7, –shBAF, or –shScram for 24 hr, followed by selection of stable integrants in the 
presence of 5 µg/ml puromycin. At 96 hpi with lentivirus, cells were infected with either 
wt or ts2 vaccinia virus (MOI = 5) and placed at 31.5°C or 39.7°C for 24 hr. Cells were then 
harvested and the yield of vaccinia virus was determined. Alternatively, at 96 hpi with 
lentivirus, cells were harvested and the rabbit α-BAF antibody was used in immunoblot 
analysis to assess the extent of BAF depletion. 
 
Dot Blot Hybridization to Assess Viral DNA Accumulation 
Confluent 35 mm-diameter dishes of 293:CAT or 293:BAF cells were infected with WT vi-
rus or ts2 at an MOI of 5 and incubated at 31.5 or 39.7°C. Cells were harvested at the indi-
cated time points (3, 7, 9, and 12 hpi). Subsequent lysis of the cells and dot blot hybridiza-
tion was performed as previously described (Boyle and Traktman, 2004). 
 
Production of Recombinant BAF and Use in Nick Translation Studies 
Dimeric BAF was expressed and purified from BL21(DE3)pLysS cells as described (Nichols 
et al., 2006). BAF was phosphorylated in vitro using purified, recombinant B1 kinase (or 
included in mock reactions containing no kinase) under conditions known to phosphory-
late BAF to completion (Nichols et al., 2006). These reactions were used as the source of 
BAF in the nick translation reactions described below. 
Nick translation reactions (11 µl) were assembled by first combining the pBR322: 
vvHindIII E plasmid, unlabeled GTP and CTP, radiolabeled ATP and TTP, and DNase I 
(200 ng/ml final concentration) on ice. Various amounts of phosphorylated or unphosphor-
ylated recombinant BAF (0, 10, 30, 100, and 350 ng) were then added to the reactions, which 
were moved to room temperature for 10 min. DNA Polymerase I (New England Biolabs, 
Ipswitch, Massachusetts) was then added to the reactions, which were then placed at 16°C 
for 1 hr. Reactions were stopped by the addition of 40 µl of TE buffer and placed on ice; 
unincorporated nucleotides were removed by size exclusion spin chromatography. DNA 
synthesis, as reflected by the incorporation of radiolabeled dNTPs into DNA, was quanti-
fied by Ҫerenkov counting. 
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Supporting Information 
 
 
 
Figure S1. Rabbit αpSer4-BAF is specific for phosphorylated BAF. The indicated amounts 
of recombinant BAF, either unphosphorylated or phosphorylated by VRK1, were sub-
jected to immunoblot analysis with the αpSer4-BAF antibody or with an αBAF serum that 
recognizes both modified and unmodified BAF. The unphosphorylated BAF was not rec-
ognized by the αpSer4-BAF antibody at any of the amounts tested. 
 
 
 
Figure S2. Minimal DNA replication occurs during nonpermissive infections of 293:BAF 
cells by ts2. 293:BAF cells were infected with either wt virus or ts2; infections were initi-
ated and maintained at 39.7°C. Parallel cultures were harvested at 7, 12, and 24 hpi, and 
the temporal profile of viral DNA replication was assessed by dot blot hybridization. Du-
plicate experiments were performed and analyzed in duplicate; the average values are 
shown, with standard errors indicated. 
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Figure S3. Recombinant virus containing pJS4-RFP-BAF expresses FLAG-BAF. Red 
plaques identified in studies shown in figure 5 were isolated and the viruses expanded 
on BSC40 cells. Infected cell lysates were subjected to immunoblot analysis using αFLAG 
or αI3 antibody. 
 
 
 
Figure S4. BAF is highly conserved in diverse eukaryotes. Conservation of N-terminal 
serine and threonine residues known to be targeted by B1 are boxed in red. Residues 
known to contribute to DNA binding and α-helices have been previously defined (Brad-
ley et al., 2005; Harris and Engelman, 2000; Segura-Totten et al., 2002; Zheng et al., 2000). 
